Qiang Nai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Qiang Nai has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Shuvendu Sen
Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 08861, USA
4 shared publicationsHongxiu Luo
Internal Medicine Residency Program, Raritan Bay Medical Center, Perth Amboy, N.J., USA
3 shared publicationsMohammed Amzad Hossain
Internal Medicine Residency Program, Raritan Bay Medical Center, Perth Amboy, N.J., USA
3 shared publicationsPing Zhang
Internal Medicine Residency Program, Raritan Bay Medical Center, Perth Amboy, N.J., USA
3 shared publicationsAbdalla M. Yousif
Internal Medicine Residency Program, Raritan Bay Medical Center, Perth Amboy, N.J., USA
2 shared publicationsKalyani Regeti
Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 08861, USA
2 shared publications
Latest Publications
- Open Access
- 1 January 2016
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 8 (8) , 610-615
Convulsive Syncope Induced by Ventricular Arrhythmia Masquerading as Epileptic Seizures: Case Report and Literature Review
Convulsive Syncope Induced by Ventricular Arrhythmia Masquerading as Epileptic Seizures: Case Report and Literature Review
- 1 January 2016
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 8 (8) , 610-615
Open AccessConvulsive Syncope Induced by Ventricular Arrhythmia Masquerading as Epileptic Seizures: Case Report and Literature Review
Convulsive Syncope Induced by Ventricular Arrhythmia Masquerading as Epileptic Seizures: Case Report and Literature Review
- Open Access
- 5 March 2015
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 8 (1) , 148-152
Elevated Erythropoietin and Multicystic Neoplasm of the Pancreas
Cystic lesions of the pancreas are more frequently recognized due to the widespread use of improved imaging techniques. There are a variety of pancreatic cystic lesions with different clinical presentations and malignant potentials, and their management depends on the type of the cysts. Although the early recognition of a cystic neoplasm with malignant potential provides an opportunity of early surgical treatment, the precise diagnosis of the cystic neoplasm can be a challenge, largely due to the lack of reliable biomarkers of malignant transformation. We report a case of a large, multicystic neoplasm within the body and tail of the pancreas complicated by elevated erythropoietin, which is likely related to the malignant transformation of the pancreatic neoplasm.
- 5 March 2015
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 8 (1) , 148-152
Open AccessElevated Erythropoietin and Multicystic Neoplasm of the Pancreas
Cystic lesions of the pancreas are more frequently recognized due to the widespread use of improved imaging techniques. There are a variety of pancreatic cystic lesions with different clinical presentations and malignant potentials, and their management depends on the type of the cysts. Although the early recognition of a cystic neoplasm with malignant potential provides an opportunity of early surgical treatment, the precise diagnosis of the cystic neoplasm can be a challenge, largely due to the lack of reliable biomarkers of malignant transformation. We report a case of a large, multicystic neoplasm within the body and tail of the pancreas complicated by elevated erythropoietin, which is likely related to the malignant transformation of the pancreatic neoplasm.
- Open Access
- 6 February 2015
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 8 (1) , 58-63
Multiple Myeloma and Atopic Eczema in an Adult
Multiple myeloma is the fourteenth cause of cancer-related death. The symptoms of myeloma are mostly nonspecific, and there is significant delay between the first symptoms and diagnosis of myeloma. Atopic eczema is a common chronic inflammatory skin disease associated with dysregulation of the immune system. It generally develops in early childhood but can also occur in adults. Eczema is associated with a variety of hematological and solid malignancies, and possibly multiple myeloma. We report a patient with eczema that developed 5 years before the diagnosis of multiple myeloma but was mistaken for psoriasis.
- 6 February 2015
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 8 (1) , 58-63
Open AccessMultiple Myeloma and Atopic Eczema in an Adult
Multiple myeloma is the fourteenth cause of cancer-related death. The symptoms of myeloma are mostly nonspecific, and there is significant delay between the first symptoms and diagnosis of myeloma. Atopic eczema is a common chronic inflammatory skin disease associated with dysregulation of the immune system. It generally develops in early childhood but can also occur in adults. Eczema is associated with a variety of hematological and solid malignancies, and possibly multiple myeloma. We report a patient with eczema that developed 5 years before the diagnosis of multiple myeloma but was mistaken for psoriasis.
- Open Access
- 3 February 2015
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 8 (1) , 46-49
How Early Can Pancreatic Cancer Be Recognized A Case Report and Review of the Literature
The early symptoms of pancreatic cancer are often very vague. They may precede the diagnosis by years and go unrecognized. This makes pancreatic cancer one of the cancers with the worst survival rates. The progression rate of the early phase might be slower than previously thought. Here, we report a case where symptoms, including thromboembolism and new-onset diabetes mellitus, preceded the diagnosis of pancreatic cancer by 6 years or longer. The awareness of the early symptoms of pancreatic cancer is required for being vigilant and further diagnostic tests. A simple clinical model utilizing certain risk factors and symptoms for pancreatic cancer will help stratify the patients for further screening tests.
- 3 February 2015
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 8 (1) , 46-49
Open AccessHow Early Can Pancreatic Cancer Be Recognized A Case Report and Review of the Literature
The early symptoms of pancreatic cancer are often very vague. They may precede the diagnosis by years and go unrecognized. This makes pancreatic cancer one of the cancers with the worst survival rates. The progression rate of the early phase might be slower than previously thought. Here, we report a case where symptoms, including thromboembolism and new-onset diabetes mellitus, preceded the diagnosis of pancreatic cancer by 6 years or longer. The awareness of the early symptoms of pancreatic cancer is required for being vigilant and further diagnostic tests. A simple clinical model utilizing certain risk factors and symptoms for pancreatic cancer will help stratify the patients for further screening tests.
- Open Access
- 20 December 2013
- Published by Springer Nature in Molecular Brain
- Vol. 6 (1) , 1-58
α7nAchR/NMDAR coupling affects NMDAR function and object recognition
The α7 nicotinic acetylcholine receptor (nAchR) and NMDA glutamate receptor (NMDAR) are both ligand-gated ion channels permeable to Ca2+ and Na+. Previous studies have demonstrated functional modulation of NMDARs by nAchRs, although the molecular mechanism remains largely unknown. We have previously reported that α7nAchR forms a protein complex with the NMDAR through a protein-protein interaction. We also developed an interfering peptide that is able to disrupt the α7nAchR-NMDAR complex and blocks cue-induced reinstatement of nicotine-seeking in rat models of relapse. In the present study, we investigated whether the α7nAchR-NMDAR interaction is responsible for the functional modulation of NMDAR by α7nAchR using both electrophysiological and behavioral tests. We have found that activation of α7nAchR upregulates NMDAR-mediated whole cell currents and LTP of mEPSC in cultured hippocampal neurons, which can be abolished by the interfering peptide that disrupts the α7nAchR-NMDAR interaction. Moreover, administration of the interfering peptide in mice impairs novel object recognition but not Morris water maze performance. Our results suggest that α7nAchR/NMDAR coupling may selectively affect some aspects of learning and memory.
- 20 December 2013
- Published by Springer Nature in Molecular Brain
- Vol. 6 (1) , 1-58
Open Accessα7nAchR/NMDAR coupling affects NMDAR function and object recognition
The α7 nicotinic acetylcholine receptor (nAchR) and NMDA glutamate receptor (NMDAR) are both ligand-gated ion channels permeable to Ca2+ and Na+. Previous studies have demonstrated functional modulation of NMDARs by nAchRs, although the molecular mechanism remains largely unknown. We have previously reported that α7nAchR forms a protein complex with the NMDAR through a protein-protein interaction. We also developed an interfering peptide that is able to disrupt the α7nAchR-NMDAR complex and blocks cue-induced reinstatement of nicotine-seeking in rat models of relapse. In the present study, we investigated whether the α7nAchR-NMDAR interaction is responsible for the functional modulation of NMDAR by α7nAchR using both electrophysiological and behavioral tests. We have found that activation of α7nAchR upregulates NMDAR-mediated whole cell currents and LTP of mEPSC in cultured hippocampal neurons, which can be abolished by the interfering peptide that disrupts the α7nAchR-NMDAR interaction. Moreover, administration of the interfering peptide in mice impairs novel object recognition but not Morris water maze performance. Our results suggest that α7nAchR/NMDAR coupling may selectively affect some aspects of learning and memory.